Skip to main content
Skip to main content
Our Company
Who We Are
Our Team
Our Science
Our Approach
Role of Progranulin
Pipeline
Overview
Frontotemporal Dementia
Patients and Caregivers
Our Commitment
Compassionate Use Statement
Community Resources
Investors and News
Overview
News
Events and Presentations
Financials and Filings
Stock Information
Investor FAQs
Resources
Corporate Governance
Inquiries and Alerts
Careers
Contact
Toggle Site Search
Search query
Search query
Our Company
Who We Are
Our Team
Our Science
Our Approach
Role of Progranulin
Pipeline
Overview
Frontotemporal Dementia
Patients and Caregivers
Our Commitment
Compassionate Use Statement
Community Resources
Investors and News
Overview
News
Events and Presentations
Financials and Filings
Stock Information
Investor FAQs
Resources
Corporate Governance
Inquiries and Alerts
Careers
Contact
Events and Presentations
Event Details
Merger Between Passage Bio and Remix Therapeutics
June 24, 2026
04:30 PM ET
Webcast
Read the latest news about Passage Bio